Alan Hofmann
Alan Hofmann (1931–2021) was an American physician and scientist renowned for his pioneering research in the field of gastroenterology, particularly in the study of bile acids and their role in digestive diseases. His work significantly advanced the understanding of cholesterol metabolism and gallstone formation.
Early Life and Education[edit | edit source]
Alan Hofmann was born in 1931. He completed his undergraduate studies at Harvard University, where he developed an interest in biochemistry. He then attended Harvard Medical School, earning his MD degree. Following his medical degree, Hofmann pursued further training in internal medicine and gastroenterology.
Career and Research[edit | edit source]
Hofmann's career was marked by his extensive research on bile acids, which are critical for the digestion and absorption of fats and fat-soluble vitamins in the small intestine. His work elucidated the complex biochemical pathways involved in bile acid synthesis and their enterohepatic circulation.
One of Hofmann's significant contributions was the development of ursodeoxycholic acid (UDCA) as a treatment for certain types of cholestatic liver diseases and gallstones. UDCA is now widely used in clinical practice to manage these conditions.
Hofmann also investigated the role of bile acids in the pathogenesis of colorectal cancer and other gastrointestinal disorders. His research provided insights into how alterations in bile acid metabolism could contribute to the development of these diseases.
Awards and Honors[edit | edit source]
Throughout his career, Hofmann received numerous awards and honors for his contributions to medical science. He was a member of several prestigious organizations, including the American Association for the Study of Liver Diseases (AASLD) and the American Gastroenterological Association (AGA).
Legacy[edit | edit source]
Alan Hofmann's work has had a lasting impact on the field of gastroenterology. His research on bile acids has paved the way for new treatments and improved understanding of various digestive diseases. He is remembered as a dedicated scientist and a mentor to many in the medical community.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD